Senseye: Partnering for Mental Health Innovation
Revolutionizing
Mental Health Diagnostics
Senseye is the first clinically validated AI-driven mental health diagnostic platform, transforming how PTSD and other conditions are identified.
- Driven by Science: Senseye leverages AI-driven computer vision to analyze ocular biomarkers validated through clinical studies
- Fast & Non-Invasive: Detects PTSD and related disorders in just 10 minutes using ocular and biometric data via smartphone.
- Objective & Reliable: Eliminates reliance on self-reported symptoms, ensuring accurate and data-driven diagnostics.
Value for
Pharma Partners
Senseye enhances pharmaceutical clinical trials with cutting-edge AI diagnostics:
Accelerated Clinical Trials:
Faster recruitment with remote, AI-driven pre-screening.
Objective Endpoints:
Eliminates subjectivity, ensuring standardized and reliable trial data.
Real-Time Monitoring:
Remote tracking of patient status for optimized treatment.
Regulatory Alignment:
Progressing toward FDA authorization, aligning with regulatory expectations.
Our Offerings
We provide end-to-end diagnostic solutions tailored for pharma partners:
Senseye “PreCheck”
Accelerates patient identification, reducing recruitment time and costs. Enables remote/decentralized screening to expand participant pools.
Senseye “Insight”
Provides continuous, objective monitoring, reducing reliance on subjective reports. Enhances sensitivity/specificity in detecting treatment effects, disease progression, and severity.
CONNECT